United Therapeutics Corporation Unrecognized Tax Benefits that Would Impact Effective Tax Rate
United Therapeutics Corporation (UTHR) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $22.80 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-02-25
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $22.80M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $16.70M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $24.00M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $15.10M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2025-12-31 | $22.80M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $16.70M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $24.00M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $15.10M 10-K · filed 2024-02-21 | |
| 2021-12-31 | $3.60M 10-K · filed 2023-02-22 | |
| 2019-09-30 | $700.00K 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $700.00K 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $300.00K 10-K · filed 2020-02-26 | |
| 2018-09-30 | $700.00K 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $300.00K 10-Q · filed 2019-07-31 | |
| 2018-03-31 | $300.00K 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $300.00K 10-K · filed 2019-02-27 | |
| 2017-09-30 | $300.00K 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-01 | |
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-02 | |
| 2016-12-31 | $300.00K 10-K · filed 2018-02-21 | |
| 2016-09-30 | $300.00K 10-Q · filed 2017-10-25 | $500.00K 10-Q · filed 2016-10-27 |
| 2016-06-30 | $300.00K 10-Q · filed 2017-07-27 | $500.00K 10-Q · filed 2016-07-28 |
| 2016-03-31 | $300.00K 10-Q · filed 2017-04-26 | |
| 2015-12-31 | $300.00K 10-K · filed 2017-02-22 | $342.00K 10-K · filed 2016-02-25 |
| 2015-09-30 | $1.50M 10-Q · filed 2016-10-27 | |
| 2015-06-30 | $1.50M 10-Q · filed 2016-07-28 | |
| 2014-12-31 | $1.00M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $2.40M 10-K · filed 2016-02-25 | |
| 2012-12-31 | $1.00M 10-K · filed 2015-02-24 | |
| 2011-12-31 | $1.30M 10-K · filed 2014-02-25 | |
| 2010-12-31 | $453.00K 10-K · filed 2013-02-26 | |
| 2009-12-31 | $538.00K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |